PregLem Starts Phase III Trials Of PGL4001 In Uterine Myoma PregLem SA, a Swiss biopharmaceutical company specialized in reproductive
medicine, announced the start of an international Phase III clinical trial program for PGL4001 (ulipristal) in symptomatic uterine myoma, a common benign solid tumor of the genital tract in women of reproductive age.
Source: www.medicalnewstoday.comTennessean Examines Debate Over Effectiveness Of 'Virginity Pledges' The Tennessean on Thursday examined the debate over the effectiveness of "virginity pledges" among teenagers. According to a recent
Source: www.medicalnewstoday.comSuccessful Robot-Assisted Surgery For Urinary Abnormality Ashok Hemal, M.D., a urologic surgeon from Wake Forest University Baptist Medical Center, and colleagues have reported success using robot-assisted laparoscopic surgery to repair abnormal openings between the bladder and vagina known as fistulas. Reporting on their experience with seven patients, Hemal and colleagues have the world's largest known success with the procedure. Their report appears online in the Journal of Urology and will be included in a future print issue.
Source: www.medicalnewstoday.comRestrictions On The Import Of Unlicensed Melatonin Products Following The Grant Of A Marketing Authorisation For Circadin(R) 2mg Tablets Dear
Healthcare Professional, Restrictions on the import of unlicensed Melatonin products following the grant of a marketing authorisation for Circadin® 2mg tablets At the beginning of June 2008, a licensed modified release melatonin product, Circadin ® (Lundbeck), became available in the UK.
Source: www.medicalnewstoday.com
# posted by Network @ 5:00 PM
